Medtronic’s 1Q Shows Slow Growth, Drop in Emerging Markets Expansion

Devices & Diagnostics Letter
Medtronic will continue to focus on increased penetration in emerging markets, despite missing a target of 20 percent growth in countries such as India and China, CEO Omar Ishrak said in a Tuesday earnings call.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00